
vTv Therapeutics Inc.
USD32.91
+0.53 (+1.64%)
CEO
Paul J. Sekhri
IPO Date
2015-07-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$31.93
Prev. Close
$32.38
Day Low
$31.68
Day High
$33.32
52W Low
$14.00
52W High
$44.00
Market Cap
$0.09B
Volume
0.07M
vTv Therapeutics and Cantex Pharmaceuticals Announce Strategic Licensing Agreement for Development and Commercialization of Azeliragon for Treatment of Cancer